(Q34609760)

3 August 2017

title

A Bayesian semiparametric survival model with longitudinal markers (English)

1 reference

3 August 2017

Song Zhang

1

1 reference

3 August 2017

Peter Müller

series ordinal

2

1 reference

3 August 2017

Kim-Anh Do

series ordinal

3

1 reference

3 August 2017

language of work or name

English

0 references

publication date

8 June 2009

1 reference

3 August 2017

1 reference

3 August 2017

volume

66

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

435-443

1 reference

maintained by WikiProject

3 August 2017

WikiProject Mathematics

0 references

cites work

Phase III trial of androgen ablation with or without three cycles of systemic chemotherapy for advanced prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045702

Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045702

Joint modelling of longitudinal measurements and event time data.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045702

A Bayesian semiparametric accelerated failure time model

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045702

A joint model for survival and longitudinal data measured with error

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045702

Models for empirical Bayes estimators of longitudinal CD4 counts.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045702

Bayesian Approaches to Joint Cure‐Rate and Longitudinal Models with Applications to Cancer Vaccine Trials

7 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2009.01276.X

Evaluating surrogate markers of clinical outcome when measured with error.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2009.01276.X

Modelling progression of CD4-lymphocyte count and its relationship to survival time.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2009.01276.X

Reversible jump Markov chain Monte Carlo computation and Bayesian model determination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2009.01276.X

The joint modeling of a longitudinal disease progression marker and the failure time process in the presence of cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2009.01276.X

Predicting time to prostate cancer recurrence based on joint models for non-linear longitudinal biomarkers and event time outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2009.01276.X

Phase II trial of alternating weekly chemohormonal therapy for patients with androgen-independent prostate cancer

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3045702

On Bayesian model and variable selection using MCMC

26 October 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2009.01276.X

10.1111/J.1541-0420.2009.01276.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference

3 August 2017

1 reference